VC-backed Pandion Therapeutics debuts IPO

Watertown, Massachusetts-based Pandion Therapeutics Inc, a developer of treatments for patients suffering from autoimmune diseases, has raised $135 million for its IPO after pricing its 7.5 million shares at $18 per share.

To read this article, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to read this article and more for free.

Share this